Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Hybrigenics' inecalcitol shows promising preclinical results against hormone-dependent prostate cancer
Yahoo/Zacks
Thursday, October 8, 2009 - 11:51am
tags:
Hybrigenics, inecalcitol, prostate cancer
Genzyme Fails to Receive Approval
Yahoo/Zacks
Thursday, October 8, 2009 - 11:49am
tags:
Genzyme, Clolar, acute myeloid leukemia
European Approval for Cimzia
Yahoo/Zacks
Thursday, October 8, 2009 - 11:44am
tags:
Cimzia, Enzon
Fresenius's APP gets a clearance for migraine drug
MarketWatch
Thursday, October 8, 2009 - 11:43am
tags:
Fresenius
Repros says it will sell 3.5M shares to investors
Yahoo/AP
Thursday, October 8, 2009 - 11:42am
tags:
Repros Therapeutics
Continuing to Accumulate Peregrine Pharma at Current Levels
Seeking Alpha
Thursday, October 8, 2009 - 11:40am
tags:
Peregrine Pharmaceuticals
Lexicon to offer 30 million shares
bizjournals.com
Thursday, October 8, 2009 - 11:39am
tags:
Lexicon Pharmaceuticals
Drugmaker MannKind Chooses Lone Wolf Strategy
ethioPlanet
Thursday, October 8, 2009 - 11:35am
tags:
MannKind, diabetes, inhaled insulin, Afresa
Centocor Ortho Biotech, Schering-Plough get European approval for Simponi
Pharmabiz
Thursday, October 8, 2009 - 11:32am
tags:
Janssen Biotech, Ortho Biotech, Schering Plough, Simponi
Sanofi says doors "wide open" to EU drugs probe
Reuters
Thursday, October 8, 2009 - 11:30am
tags:
Sanofi
Dr Reddy Lab in demand as GSK eyes stake
India Infoline
Thursday, October 8, 2009 - 11:14am
tags:
Dr Reddy's, GSK
Biostar Pharmaceuticals, Inc. Receives The Chinese Military Drug Administration Clearance To Begin Clinical Trial For Zushima Analgesic Aerosol Spray
Pharmaceutical Online
Thursday, October 8, 2009 - 11:10am
tags:
Biostar Pharmaceuticals
Novartis Gets Rights To Broad-Spectrum Antibiotic
Wall Street Journal
Thursday, October 8, 2009 - 11:09am
tags:
Novartis, PTK 0796, Paratek
IMS Health ups pharma sales view
MarketWatch
Thursday, October 8, 2009 - 11:06am
tags:
IMS
Targacept Announces Common Stock Offering
Yahoo/BusinessWire
Thursday, October 8, 2009 - 11:04am
tags:
Targacept
Lpath's iSONEP Is Well Tolerated at All Dose Levels in a Phase 1 Trial in Wet-AMD Patients
Yahoo/MarketWire
Thursday, October 8, 2009 - 11:02am
tags:
Lpath, iSONEP, wet-AMD
Advaxis Live Listeria Vaccine Induces Epitope Spreading
Yahoo/BusinessWire
Thursday, October 8, 2009 - 10:58am
tags:
Advaxis, Epitope, cancer
Fresenius's APP gets a clearance for migraine drug
Marketwatch
Thursday, October 8, 2009 - 8:37am
tags:
Fresenius, APP, migraines, GSK, generics, Imitrex
Repros Therapeutics stock more than doubles on positive study results for Androxal
Yahoo/AP
Thursday, October 8, 2009 - 8:36am
tags:
Repros Therapeutics, Androxal
The inside scoop on Roche's integration of Genentech
Fierce Pharma
Thursday, October 8, 2009 - 8:34am
tags:
Roche, Genentech, restructuring, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.